Fluorescent Determination of Butyrylcholinesterase Activity and Its Application in Biological Imaging and Pesticide Residue Detection
- 27 January 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 6 (3) , 1138-1146
Abstract
Butyrylcholinesterase (BChE) is an essential human cholinesterase relevant to liver conditions and neurodegenerative diseases, which makes it a pivotal biomarker of health. It therefore remains challenging and highly desired to elaborate efficient chemical tools for BChE with simple operations and satisfactory working performance. In this work, a background-free detection strategy was built by virtue of the judicious coupling of a specific BChE-enzymatic reaction and in situ cyclization. High sensitivity with a low limit of detection (LOD) of 0.075 μg/mL could be readily achieved from the blank background and the as-produced emissive indicators, and the specific reaction site contributed to the high selectivity over other bio-species even acetylcholinesterase (AChE). In addition to the multifaceted spectral experiments to verify the sensing mechanism, this work assumed comprehensive studies on the application. The bio-investigation ranged from cells to an organism, declaring a noteworthy prospect in disease diagnosis, especially for Alzheimer’s disease (AD), a common neurodegenerative disease with over-expressed BChE. Moreover, its excellent work for inhibition efficacy elucidation was also proved with the accuracy IC50 of tacrine for BChE (8.6 nM), giving rise to an expanded application for trace pesticide determination.Keywords
Funding Information
- Ministry of Education of the People's Republic of China (SCAI1702, SCAI1703)
- National Natural Science Foundation of China (21904077, 22004078, 22074074)
- Natural Science Foundation of Shandong Province (ZR2019BB055)
- Xiamen University
- Key Laboratory of Spectrochemical Analysis & Instrumentation, Xiamen University
This publication has 51 references indexed in Scilit:
- Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s DiseaseJournal of Alzheimer’s Disease, 2017
- New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial ParameterPLOS ONE, 2015
- Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic usesPharmacology & Therapeutics, 2015
- Syntheses of coumarin–tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretaseBioorganic & Medicinal Chemistry, 2014
- Serum cholinesterase is an excellent biomarker of liver cirrhosisTropical Gastroenterology, 2014
- Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's diseaseNeurobiology of Aging, 2013
- Design, synthesis, and bioevaluation of benzamides: Novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Aβ aggregation, and β-secretaseBioorganic & Medicinal Chemistry, 2012
- CHOLINESTERASES, A TARGET OF PHARMACOLOGY AND TOXICOLOGYBiomedical Papers, 2011
- Butyrylcholinesterase activity in young men and women: Association with cardiovascular risk factorsClinical Biochemistry, 2011
- The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology♦Journal of Biological Chemistry, 2009